ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2019, Vol. 28 ›› Issue (1): 78-82.DOI: 10.3969/j.issn.1006-298X.2019.01.017

• 论文 • 上一篇    下一篇

多发性骨髓瘤的诊断和治疗进展

  

  • 出版日期:2019-02-28 发布日期:2019-03-04

Update on diagnosis and treatment of multiple myeloma

  • Online:2019-02-28 Published:2019-03-04

摘要:

多发性骨髓瘤(MM)是一种细胞遗传学高度异质性的克隆性浆细胞恶性肿瘤,其发病率高、个体间预后差异大、治疗难度大。近年来,肿瘤发生学、细胞遗传学和分子生物学的研究取得丰硕成果,这些成果促进了MM诊断标准和预后分层系统的更新,推动了新药研发和联合化疗方案的更新,使MM患者精准的个体化治疗成为可能。本文对MM的诊断及治疗新进展进行综述。

关键词: 多发性骨髓瘤, 诊断, 治疗

Abstract:

Multiple myeloma (MM) is a clonal plasma cell proliferative disorder with significant cytogenetic heterogeneity,which has high morbidity and different clinical outcome between individuals,making it relatively difficult to treat with traditional chemotherapy agents.In recent years,with the further understanding of tumorigenicity,cytogenetic and molecular biology,the criteria for the diagnosis of MM, the prognosis and risk stratification of patients have been updated.Combining with the application of new drugs and combination chemotherapy regimens,it is possible to individualize prescription of medical treatment for MM patients in the near future.This article summarizes the recent advances in the diagnosis,riskstratification and management of MM.

 

Key words: multiple myeloma, diagnosis, treatment